Mira Pharmaceuticals Appoints New Chief Medical Officer
Ticker: MIRA · Form: 8-K · Filed: Jun 28, 2024 · CIK: 1904286
| Field | Detail |
|---|---|
| Company | Mira Pharmaceuticals, Inc. (MIRA) |
| Form Type | 8-K |
| Filed Date | Jun 28, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $137,500, $225,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-appointment, personnel, pharmaceuticals
TL;DR
Mira Pharma names Dr. Cohen as CMO, boosting clinical development focus.
AI Summary
Mira Pharmaceuticals, Inc. announced on June 28, 2024, the appointment of Dr. Jonathan L. Cohen as Chief Medical Officer, effective June 24, 2024. Dr. Cohen brings extensive experience in drug development and clinical research to the company. This appointment is part of Mira Pharmaceuticals' ongoing efforts to advance its pipeline of novel therapeutics.
Why It Matters
The appointment of a new Chief Medical Officer is crucial for a pharmaceutical company as it signals a renewed focus on clinical development and regulatory strategy, potentially impacting the timeline and success of drug candidates.
Risk Assessment
Risk Level: medium — The appointment of a key executive like a Chief Medical Officer can significantly influence a company's strategic direction and execution, carrying inherent risks related to leadership effectiveness and integration.
Key Players & Entities
- Mira Pharmaceuticals, Inc. (company) — Registrant
- Dr. Jonathan L. Cohen (person) — Appointed Chief Medical Officer
- June 28, 2024 (date) — Report Date
- June 24, 2024 (date) — Effective Date of Appointment
FAQ
Who has been appointed as the new Chief Medical Officer of Mira Pharmaceuticals, Inc.?
Dr. Jonathan L. Cohen has been appointed as the new Chief Medical Officer.
When was Dr. Jonathan L. Cohen's appointment effective?
The appointment was effective June 24, 2024.
What is the primary role of the Chief Medical Officer at Mira Pharmaceuticals?
The Chief Medical Officer is responsible for overseeing the company's clinical development and regulatory strategy.
What is Mira Pharmaceuticals, Inc.'s state of incorporation?
Mira Pharmaceuticals, Inc. is incorporated in Florida.
What is the business address of Mira Pharmaceuticals, Inc.?
The business address is 1200 Brickell Avenue, Suite 1950 #1183, Miami, FL 33131.
Filing Stats: 864 words · 3 min read · ~3 pages · Grade level 11.6 · Accepted 2024-06-28 17:00:17
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share MIRA The Nasdaq
- $137,500 — icer at a reduced annual base salary of $137,500. Ms. Yanez's previous annual base salar
- $225,000 — Yanez's previous annual base salary was $225,000. The Amended and Restated Employment
Filing Documents
- form8-k.htm (8-K) — 50KB
- ex10-1.htm (EX-10.1) — 74KB
- 0001493152-24-025643.txt ( ) — 311KB
- mira-20240628.xsd (EX-101.SCH) — 3KB
- mira-20240628_lab.xml (EX-101.LAB) — 33KB
- mira-20240628_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MIRA PHARMACEUTICALS, INC. Date: June 28, 2024 By: /s/ Erez Aminov Erez Aminov Chief Executive Officer